Lopinavir and cushing's syndrome Patient Reports February 11, 2012
Lopinavir Side Effects Report #5357794-0
Lopinavir side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Male patient, child 9 years of age, weighting 53.57 lb, was diagnosed with hiv infection cdc category a1
, asthma
, rhinitis allergic and was treated with Lopinavir. After drug was administered, patient experienced the following side effects: cushing's syndrome. Lopinavir dosage: 216/54 MG (230/57.5 MG/M2) TWICE DAILY(230/57.5 MG/M**2 ) TWICE DAILY. During the same period patient was treated with FLUTICASONE PROPIONATE, MOMETASONE FUROATE, DIDANOSINE, LAMIVUDINE, MONTELUKAST. Patient recovered.Lopinavir Side Effects Report #5365718-5
Lopinavir side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, child 9 years of age, weighting 53.57 lb, was diagnosed with hiv infection cdc category a1
, asthma
, rhinitis allergic and was treated with Lopinavir. After drug was administered, patient experienced the following side effects: cushing's syndrome. Lopinavir dosage: 216/54 MG (230/57.5 MG/M2) TWICE DAILY(230/57.5 MG/M**2 ) TWICE DAILY. During the same period patient was treated with FLUTICASONE PROPIONATE, MOMETASONE FUROATE, DIDANOSINE, LAMIVUDINE, MONTELUKAST. Patient recovered.Lopinavir Side Effects Report #6055888-8
Lopinavir side effect was reported by a Consumer or non-health professional from SPAIN on Jan 14, 2009. Male patient, 54 years of age, was diagnosed with hiv infection
, bronchospasm and was treated with Lopinavir. After drug was administered, patient experienced the following side effects: bronchospasm, central obesity, cushing's syndrome, cushingoid, lipohypertrophy, respiratory tract infection, skin striae. Lopinavir dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.Lopinavir Side Effects Report #6056008-6
Lopinavir side effect was reported by a Consumer or non-health professional from SPAIN on Jan 26, 2009. Male patient, 54 years of age, was diagnosed with hiv infection
, bronchospasm and was treated with Lopinavir. After drug was administered, patient experienced the following side effects: bronchospasm, central obesity, cushing's syndrome, cushingoid, lipohypertrophy, respiratory tract infection, skin striae. Lopinavir dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.Lopinavir Side Effects Report #6056274-7
Lopinavir side effect was reported by a Consumer or non-health professional from SPAIN on Jan 26, 2009. Male patient, 54 years of age, was diagnosed with hiv infection
, bronchospasm and was treated with Lopinavir. After drug was administered, patient experienced the following side effects: bronchospasm, central obesity, cushing's syndrome, cushingoid, lipohypertrophy, respiratory tract infection, skin striae. Lopinavir dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.Lopinavir Side Effects Report #4660653-X
Lopinavir side effect was reported by a Consumer or non-health professional from on May 03, 2005. Female patient, 27 years of age, was diagnosed with hiv infection
, asthma
and was treated with Lopinavir. After drug was administered, patient experienced the following side effects: cushing's syndrome, hypothalamo-pituitary disorders, myopathy, weight increased. Lopinavir dosage: 800 MG/200 MG. During the same period patient was treated with FLUTICASONE PROPIONATE, METHADONE HYDROCHLORIDE, BENZODIAZEPINES, SAQUINAVIR. Patient recovered.
Lopinavir and cushing's syndrome 